C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2002
10/03/2002	US20020142388 Bacterial host strains
10/03/2002	US20020142387 Methods for producing protein domains and analyzing three dimensional structures of proteins by using said domains
10/03/2002	US20020142386 Engineering intracellular sialylation pathways
10/03/2002	US20020142384 Generating soluble active recombinat proteins; obtain vector, insert preferential binding domain into vector, transform cell, propagate induce expresion of recombinant protein
10/03/2002	US20020142378 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/03/2002	US20020142376 Peptide for use in the diagnosis and treatment of nervous system disorders
10/03/2002	US20020142375 Nucleotide sequences coding G protein coupled receptors for use in the diagnosis and treatment of cancer, adult respiratory distress, nervous system disorders and arthritis
10/03/2002	US20020142374 Generating genetically engineered antibody with expanded half-life; obtain nucleotide sequences, insert segment coding preferential immunoglobulin fragment, recover protein
10/03/2002	US20020142373 Tissue factor protein variants
10/03/2002	US20020142372 Fragments of cr1 and their use
10/03/2002	US20020142371 Detecting target polynucleotides in a test sample; obtain sample, incubate with probe, detect signal, presence of signal indicates target sequences
10/03/2002	US20020142370 Practical in vitro sialylation of recombinant glycoproteins
10/03/2002	US20020142369 Refolding method of thrombin
10/03/2002	US20020142363 Medical diagnosis, therapy; detecting binding of proteins
10/03/2002	US20020142359 Monoclonal antibody to CEA, conjugates comprising said antibody, and their therapeutic use in an adept system
10/03/2002	US20020142358 Antibody for use in the diagnosis, prevention and treatment of infections, multiple sclerosis, arthritis, autoimmune, inflammation and graft versus host disease
10/03/2002	US20020142357 TNF receptor action modulation
10/03/2002	US20020142355 Methods for the in vivo biotin labeling of polypeptides
10/03/2002	US20020142353 Connective tissue growth factor (CTGF) and methods of use
10/03/2002	US20020142351 Peptide or protein microassay method and apparatus
10/03/2002	US20020142350 Viral nucleotide sequences for use in the prevention and treatment of viral diseases
10/03/2002	US20020142347 Biosensor
10/03/2002	US20020142343 Preparing substrate for detecting preferential particle in sample; obtain sample, expose to elution buffer, detect preferential particle by desorption spectrometry, incubate with substrate, recover preferential particle
10/03/2002	US20020142342 Nucleic acid analysis using non-templated nucleotide addition
10/03/2002	US20020142338 Compositions and methods for inhibiting motor neuron degeneration
10/03/2002	US20020142337 Hybrid nucleotide sequence library for use as tool in genetic engineering
10/03/2002	US20020142333 Heat resistant enzymatic polypeptide for use as a tool in nucleotide sequences analysis
10/03/2002	US20020142331 Construction of uni-directionally cloned cDNA libraries from messenger RNA for improved 3' end DNA sequencing
10/03/2002	US20020142330 Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
10/03/2002	US20020142327 Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
10/03/2002	US20020142326 Screening sample for preferential microorganisms; obtain sample, inubate with probes, detect hybridization, classify microorganisms
10/03/2002	US20020142324 Preparing clonal library of genetically engineered nucleotide sequences; obtain nucleotide sequences, incubate with vector and enzyme, seal nucleotide sequences into vector, transform cells, recover clonal library
10/03/2002	US20020142321 Method for the evolutionary design of biochemical reaction networks
10/03/2002	US20020142316 Mutants of the factor VII-activating protease and detection methods using specific antibodies
10/03/2002	US20020142314 Complexity management and analysis of genomic data
10/03/2002	US20020142311 Genetic modification in the gene for human G protein beta3 subunit for the diagnosis of diseases
10/03/2002	US20020142299 PTD-modified proteins
10/03/2002	US20020142296 Screening and use of reagents which block or activate intein splicing utilizing natural or homologous exteins
10/03/2002	US20020142292 Mammalian genes; related reagents and methods
10/03/2002	US20020142284 Detecting kidney protective agent; obtain cells, incubate with modulator, measure nucleotide sequence expression, compare to control, monitor adjustment in nucleotide sequences expresion
10/03/2002	US20020142283 Inhibitors of C-reactive protein induced inflammation
10/03/2002	US20020142282 Immortalized human keratinocyte cell line
10/03/2002	US20020142281 Monitoring the activity of trascrption factor; obtain cell, transform with vector coding transcription factor, monitor expression of reporter molecules
10/03/2002	US20020142011 Vaccine
10/03/2002	US20020142007 Intracellular delivery vehicles
10/03/2002	US20020142001 DNA immunization against Chlaymdia infection
10/03/2002	US20020142000 Genetic engineering
10/03/2002	US20020141992 Deactivation of collagen receptors
10/03/2002	US20020141991 Methods of treating inflammatory disease using antibodies which bind GPR-9-6
10/03/2002	US20020141989 Antiinflammatory agents; antiallergens
10/03/2002	US20020141983 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
10/03/2002	US20020141982 Gene therapy methods using bone marrow-derived cells
10/03/2002	US20020141980 Convection-enhanced delivery of AAV vectors
10/03/2002	US20020141978 Retroviral vectors
10/03/2002	US20020141973 Reducing number of tumor cells
10/03/2002	US20020139751 For affinity capture of biomolecules to meet needs for life sciences such as proteomics and drug discovery
10/03/2002	US20020139012 Methods for identifying modulators of N-type ion channel inactivation
10/03/2002	CA2664797A1 Cytotoxic factors for modulating cell death
10/03/2002	CA2633522A1 Methods for delivering nucleic acid molecules into cells and assessment thereof
10/03/2002	CA2444186A1 Nucleic acid reactions using labels with different redox potentials
10/03/2002	CA2443676A1 A novel modulator of non-genomic activity of nuclear receptors (mnar) and uses thereof
10/03/2002	CA2442325A1 Shellfish protein
10/03/2002	CA2442254A1 Site-targeted transformation using amplification vectors
10/03/2002	CA2442232A1 Methods and nucleic acids for the analysis of hematopoietic cell proliferative disorders
10/03/2002	CA2442089A1 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
10/03/2002	CA2442071A1 Isolated human metalloprotease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
10/03/2002	CA2442019A1 Sex-specific selection of sperm from transgenic animals
10/03/2002	CA2442010A1 New elongase gene and production of.delta. 9-polyunsaturated fatty acids
10/03/2002	CA2442004A1 Microbial feeds for aquaculture and agriculture
10/03/2002	CA2441986A1 Methods and products related to fgf dimerization
10/03/2002	CA2441938A1 Method of evaluating useful cattle
10/03/2002	CA2441910A1 Culture medium for cell growth and transfection
10/03/2002	CA2441721A1 Human potassium channel
10/03/2002	CA2441708A1 Mch1r deficient mice
10/03/2002	CA2441706A1 A new essential downstream component of the wingless signalling pathway
10/03/2002	CA2441700A1 Polypeptides and nucleic acids for bolekine
10/03/2002	CA2441691A1 Compositions and methods of zearalenone detoxification
10/03/2002	CA2441688A1 Compositions and methods useful for hcv infection
10/03/2002	CA2441684A1 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof
10/03/2002	CA2441663A1 Viral vectors and their use in therapeutic methods
10/03/2002	CA2441604A1 Methods for the synthesis of polynucleotides and combinatorial libraries of polynucleotides
10/03/2002	CA2441594A1 Method of enhancing entomophilous
10/03/2002	CA2441580A1 Coagulation factor vii derivatives
10/03/2002	CA2441551A1 Pathogenic and commensal vaccine antigens
10/03/2002	CA2441437A1 Device for referencing fluorescence signals
10/03/2002	CA2441378A1 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
10/03/2002	CA2441346A1 Transformants producing substance pf1022 derivatives, methods for producing the same, and novel biosynthesis genes
10/03/2002	CA2441287A1 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
10/03/2002	CA2441267A1 Stereoselective reduction of substituted acetophenone
10/03/2002	CA2440676A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002	CA2440378A1 Arrayed transfection method and uses related thereto
10/03/2002	CA2440322A1 Oligonucleotide conjugates
10/03/2002	CA2440133A1 Methods for purifying and detecting double stranded dna target sequences by triple helix interaction
10/03/2002	CA2439961A1 Human cytokine receptor
10/03/2002	CA2439678A1 Uses of opg ligand to modulate immune responses
10/03/2002	CA2439630A1 Use of biomolecular targets in the treatment and visualization of brain tumors
10/03/2002	CA2439431A1 Streptococcus pneumoniae proteins and nucleic acids
10/03/2002	CA2439098A1 Mutation detection using muts and reca
10/03/2002	CA2438473A1 Soybean isoflavone reductase 1 promoter
10/03/2002	CA2438206A1 Transporters and ion channels

1 ... 2697 2698 2699 2700 2701 2702 2703 2704 2705 2706 2707 2708 2709 2710 2711 2712 2713 2714 2715 2716 2717 ... 4023